State of China Life Science 2020

EXCLUSIVE REPORT

State of China Life Science - 2020 H1

Topics inside report:

VC Funds Raised
VC Investment
M&A Activity
IPOs
Partnering Activity

EBD Group Inc., 3150 Pio Pico Drive, Suite 201, Carlsbad, CA 92008

Forge cross-border partnerships during ChinaBio® Partnering Forum, Delivered Digitally, August 25–27, 2020

August 25–27, 2020
China Standard Time

Terms and Conditions | Privacy Policy

Things are looking up in spite of COVID-19.

VC, IPO and Partnering are rebounding, but M&A continues to slump.

Download this new in-depth analysis of investment and partnering activity in China for 2020 H1 by ChinaBio^® to discover the factors driving China life science investment.

Report produced by:

Terms and Conditions | Privacy Policy

DOWNLOAD
YOUR COPY TODAY

Country *

First Name *

Surname *

Email *

Phone Number

Job Title

Company Name

Please tick these boxes if you do not wish to receive marketing information relevant to you from EBD Group

via Email

via Telephone

via Post

Please tick this box if you do not wish to be included on our third party mailing list to receive any related marketing communications from our third party partners